NCT01807702View on ClinicalTrials.gov

13C-Pyruvate Breath Test

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy
Interventions
DRUG

13C-Pyruvate 13C-lactate and dichloroacetate

Subjects will receive pyruvate and have blood,CO2, and buccal cell samples collected. The second visit the subjects will receive a dose of dichloroacetate before the pyruvate is given

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01807702 - 13C-Pyruvate Breath Test | Biotech Hunter | Biotech Hunter